SBIR Phase II: Microchip Assay for Glycosylated Hemoglobin

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0548744
Agency Tracking Number: 0419441
Amount: $468,024.00
Phase: Phase II
Program: SBIR
Awards Year: 2006
Solicitation Year: 2003
Solicitation Topic Code: BT
Solicitation Number: NSF 03-535
Small Business Information
P O Box 272908, Fort Collins, CO, 80525
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Dale Willard
 (970) 402-3117
Business Contact
 Dale Willard
Title: Dr
Phone: (970) 491-4064
Research Institution
This Small Business Innovation Research (SBIR) Phase II project aims at developing the next generation of diabetic monitoring devices that will allow the measurement of multiple markers of disease regulation and progression using an innovative lab-on-a-chip technology. The project will develop the first integrated microchip CE device for measurement of an important maker of diabetes.

This technology will impact patient monitoring for disease progression and therapeutic efficacy by following biomarker more efficiently as well as being used at the point of care. This eliminates the time and cost currently required to perform follow up laboratory tests. The technology approaches the chemistry of biomarkers from a non-traditional sensor mechanism and shows great promise for the detection and use of biomarkers for specific diseases.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government